Join our in experts, in a discussion driven by you, as they tackle:

  • The importance of an integrated formulation development and clinical supply function that can support accelerated timelines to clinic, including complex formulations
  • Recent and ongoing experiences in liposomal formulations, with focus on high pressure homogenization
  • Linearity of laboratory to clinical supply scale-up with supporting analytics
  • Broad applicability to variety of product types and presentations (liquid, lyophilized, potent compounds, cytotoxics)


Have questions you want answered?

Submit your questions in advance of this event by email sent to




Iain MacGilp, Ph.D.

Director, GMP Production


Dr. Iain MacGilp is the Director of GMP Manufacturing for AMRI Glasgow. He earned his Ph.D. in Chemistry from the University of Strathclyde, Glasgow. He has been with AMRI for 14 years. Prior to that, he spent 11 years with GSK in chemical development and broader CMC development roles.

Amber McFarlane

Head of Formulation Development


Amber McFarlane is the Head of Formulation Development, working out of AMRI's Glasgow, UK site. Amber has a Master of Science (MSc) degree in chemistry and has spent the past seven years at AMRI.

Scientific Expertise. Market-Leading Technology.
Best-in-Class Solutions.

AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. With locations in North America, Europe and Asia, AMRI’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Discovery, Development, Analytical Services, API Manufacturing and Drug Product. We’ve got it down to an exact science.

Discover our Expert Solutions


YES, I would like to register for this webinar: